BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a naturally occurring protein found in gastric juice. Since its isolation, it has been the subject of extensive preclinical research examining its interactions with several key biological pathways. This article provides researchers with an overview of the compound’s proposed mechanisms and the current state of the scientific literature. Researchers looking to source BPC-157 for laboratory use can view our BPC-157 research compound or browse the full peptide encyclopedia for further compound profiles.
Molecular Profile
BPC-157 has the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and is assigned the CAS number 137525-51-0. Unlike endogenous peptides, BPC-157 demonstrates notable stability in aqueous environments, including human gastric juice, which has made it a practical subject for laboratory investigation across multiple administration routes in animal models.
Proposed Mechanisms of Action
Preclinical research has identified several pathways through which BPC-157 may exert its observed effects in animal models. These include:
Angiogenesis and VEGFR2 Upregulation
Multiple studies have reported that BPC-157 appears to stimulate the formation of new blood vessels through upregulation of vascular endothelial growth factor receptor 2 (VEGFR2). A key study by Hsieh et al. (2017) demonstrated that BPC-157 promotes VEGFR2 internalization in vascular endothelial cells and activates the VEGFR2-Akt-eNOS signalling pathway, producing measurable pro-angiogenic effects both in vitro and in vivo. Earlier work by Brcic et al. (2009) correlated BPC-157 administration with upregulated VEGF expression in muscle and tendon healing models, providing foundational evidence for its angiomodulatory activity.
Nitric Oxide System Modulation
Research has indicated that BPC-157 interacts with the nitric oxide (NO) system, with evidence suggesting it can modulate NO synthesis while counteracting free radical formation. A review by Sikiric et al. (2013) concluded that BPC-157 acts as a potent angiomodulatory agent operating through NO, VEGF, and FAK vasoactive pathways, optimising vascular response following tissue injury. This interaction may contribute to its observed cytoprotective effects across gastrointestinal and vascular tissues in animal studies.
Growth Hormone Receptor Interaction
A 2024 systematic review published in an orthopaedic sports medicine journal, covering 36 studies from 1993 to 2024, reported that BPC-157 enhances growth hormone receptor expression alongside several pathways involved in cell growth and angiogenesis, while reducing inflammatory cytokines. This review also highlighted that the evidence base remains almost entirely preclinical, with only one human study identified across the entire literature.
Tendon and Collagen Pathways
In vitro and in vivo studies have examined BPC-157’s effects on tendon fibroblast activity and collagen organisation. A 2025 narrative review in PMC described BPC-157’s pleiotropic regenerative properties across musculoskeletal tissues, noting its activation of ERK1/2 signalling and its effects on fibroblast proliferation, migration, and vascular tube formation — mechanisms relevant to tendon and connective tissue repair research.
Current Research Landscape
The substantial majority of BPC-157 research to date has been conducted in rodent models, with studies investigating effects across gastrointestinal injury, musculoskeletal tissue, neurological models, and systemic inflammatory contexts. The volume of preclinical data is considerable, with over 190 publications indexed on PubMed. However, it is worth noting that independent replication remains limited — a 2025 commentary noted that over 80% of BPC-157 publications originate from a single research group, which is an important consideration when evaluating the robustness of findings.
As of the current date, BPC-157 has not progressed to published Phase II or Phase III human clinical trial data in the peer-reviewed literature, and its mechanisms of action in human subjects remain unestablished. Researchers should approach the existing literature with appropriate consideration of the translational gap between rodent models and human physiology. For related longevity and tissue repair compounds, researchers may also wish to explore our articles on Epithalon and GHK-Cu, or browse our Growth Factors, Longevity & Anti-Ageing, and research compound catalogue.
Key Takeaways
- BPC-157 is a 15-amino acid synthetic peptide derived from gastric juice protein, with notable aqueous stability.
- Proposed mechanisms in preclinical models include VEGFR2-mediated angiogenesis, nitric oxide system modulation, and collagen pathway interaction.
- The existing evidence base is almost entirely preclinical, with the majority of studies conducted in rodent models.
- Independent replication of findings across research institutions remains limited — a key consideration when interpreting the literature.
- No peer-reviewed Phase II or III human clinical trial data is currently available in the published literature.
Frequently Asked Questions
What does BPC stand for?
BPC stands for Body Protection Compound. The designation reflects its origin as a fraction isolated from gastric juice proteins, where it was identified during research into endogenous cytoprotective factors.
Is BPC-157 naturally occurring?
BPC-157 is a synthetic peptide derived from a naturally occurring parent protein found in gastric juice. The 15-amino acid sequence used in research is a partial sequence that does not occur in this exact isolated form in nature. For further background, see our peptide encyclopedia entry on BPC-157.
What research models have been used to study BPC-157?
The preponderance of BPC-157 research has used rat and mouse models. Studies have examined intraperitoneal, intragastric, subcutaneous, and topical administration routes across a range of injury and disease models. For a broader overview of research peptide categories, visit our research hub.
This content is intended for researchers and scientific professionals only. All compounds referenced are for laboratory research use exclusively. Nothing in this article constitutes medical advice or implies suitability for human use.
